Courageous Discourse™ with Dr. Peter McCullough & John Leake

Share this post

BREAKING--Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

petermcculloughmd.substack.com

Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake

Advancement of clinical science, protection of personal autonomy, liberty, and constitutional rights.
Over 91,000 subscribers
Continue reading
Sign in

BREAKING--Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

Emergency Authorization Granted without Emergency or Human Data

Peter McCullough, MD
Sep 13, 2023
578
Share this post

BREAKING--Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

petermcculloughmd.substack.com
81
Share

By Peter A. McCullough, MD, MPH

At this point, the American public and scientific community is flabbergasted at the complete regulatory malfeasance committed by US FDA VRBPAC and CDC panelists. As of September 12, 2023, the prior bivalent (original Wuhan /BA4/BA5 mRNA Code) has been retired and the new XBB.1.5 monovalent vaccines have been emergency use authorized. From the Pfizer core slides released today, there was a single experiment with 10 mice assigned to the prior BA4/BA5 bivalent and 10 assigned to the new XBB.1.5 monovalent vaccine. They were injected twice, 21 days apart. The new booster was authorized for a single 30 mcg shot in humans.

The pseudoviral antibody responses were greater for the new vaccine against the outgoing XBB.1.5 (3.1% of strains as of 9/2/23) and the incoming EG.5 (Eris) strain at 21.5%, but no information was given about and FL.1.5.1 which is growing at 14.5% in the US population.

There were no human studies presented in the core slides by Pfizer. It impossible to predict what would happen with a single human injection. Their last slide was a single ongoing clinical study of the new vaccine. There are two age groups, no randomization and no control group. There is zero chance to assess human safety or efficacy of the XBB.1.5 vaccine in sponsored studies.

The only thing that will stop ongoing scientific misconduct and regulatory malfeasance is public outrage and booster refusal. The vaccine companies are hauling in record profits, have not analyzed safety nor have they shown any interest in safer more effective products for testing in large-scale randomized double-blind placebo controlled trials. The Bio-Pharmaceutical Complex is completely off the rails! Coming next will be vaccines developed from computer generated mRNA genetic code with mathematical modeling of antibody response and no mice or human subjects at all.

Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.

Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Peter A. McCullough, MD, MPH

President, McCullough Foundation

www.mcculloughfnd.org

Monovalent XBB.1.5 BNT162b2 COVID-19 Vaccine ACIP Presentation September 12, 2023

578
Share this post

BREAKING--Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

petermcculloughmd.substack.com
81
Share
81 Comments
Share this discussion

BREAKING--Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

petermcculloughmd.substack.com
Margaret Anna Alice
Writes Margaret Anna Alice Through the…
Sep 13

JUST SAY NO.

Expand full comment
Reply
Share
5 replies
PamelaDrew
Writes Pamela Drew #my2c
Sep 13

In case anyone imagined the public is seen as more than lab rats all doubt is removed!

Expand full comment
Reply
Share
8 replies
79 more comments...
Top
New
Community

No posts

Ready for more?

© 2023 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing